Clinical Trial Update: Cardiotoxicity of Cancer Therapy (CCT)

View source ↗

Summary

The Cardiotoxicity of Cancer Therapy (CCT) trial, sponsored by the Abramson Cancer Center at Penn Medicine, is enrolling by invitation in breast cancer patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Breast Cancer | Status: ENROLLING_BY_INVITATION